People · Operator
Named in public records as an officer, director or promoter · active 2021–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Monod Bio, Inc. | — | Biotechnology | Series B | $30.2M | $418.0M | 2021 |
Daniel Adriano Silva Manzano at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Adriano Silva Manzano on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alfredo A Quijano Rubio | 1 | 1 |
| Karan A Takhar | 1 | 1 |
| Dave Adriano Johnson | 1 | 1 |
| Berta Melina Cimler | 1 | 1 |
| David A Shoultz | 1 | 1 |
| Dave Melina Johnson | 1 | 1 |
| David Melina Shoultz | 1 | 1 |
| Alfredo Quijano Rubio | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.